Recipient Hyperbilirubinemia May Reduce Ischemia-Reperfusion Injury but Fails to Improve Outcome in Clinical Liver Transplantation
Background. Exogenous bilirubin may reduce experimental ischemia-reperfusion injury (IRI) due to its antioxidant properties. We studied if early graft exposure to high bilirubin levels in the recipient affects the early IRI and outcomes after liver transplantation (LTx). Methods. In 427 LTx patients...
Saved in:
Main Authors: | Mihai Oltean, Christian Barrenäs, Paulo Ney Martins, Gustaf Herlenius, Bengt Gustafsson, Styrbjörn Friman, William Bennet |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/6964856 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of cytokines in myocardial ischemia and reperfusion
by: H. S. Sharma, et al.
Published: (1997-01-01) -
A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients
by: Ulf Neumann, et al.
Published: (2012-01-01) -
The Role of Tetrahydrobiopterin and Dihydrobiopterin in Ischemia/Reperfusion Injury When Given at Reperfusion
by: Qian Chen, et al.
Published: (2010-01-01) -
Ischemia/Reperfusion Injury, Its Mechanisms, and Prevention
by: Maciej Kosieradzki, et al.
Published: (2012-01-01) -
Effects of noncoding RNAs in intestinal ischemia-reperfusion
by: Tingcong Lv, et al.
Published: (2025-02-01)